Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • geschickten
    Member
    • Jul 2009
    • 31

    #1

    Bio-Cloud from India

    Hi All,

    Geschickten Solutions is a Bio-Cloud services company based in Bangalore, India. We provide computational biology and High Performance Computing solutions. We are experts when it comes to HPC/Cloud computing but we are relatively new to Bioinformatics. We are working on various opensource tools and also developing algorithms for de novo assembly.

    We aim to start complete sequencing service in India by end of this year. Since we are good at High Performance computing we would enable sequencing in the Cloud.

    We are open for collaborations/tie-up's ( we are also hiring; part-time/full-time); I also request to kindly give your valuable suggestions/strategy on what we should do as a sequencing services company. Thank you.

    Best regards,
    Prahalad
  • ECO
    --Site Admin--
    • Oct 2007
    • 1360

    #2
    Hey Prahalad/Geschickten...

    I'm doing my best to keep overtly commercial postings off the site...so please email me at eric [<(at)]]> seqanswers.com before posting again! Please don't be insulted as I am trying to protect the community from unwanted commercial intrusions, in fact I probably have some interesting proposals if you are indeed experts in the cloud.

    Thanks for understanding. I'm moving this to the vendor forum for now.

    Best,
    -=E

    Comment

    • geschickten
      Member
      • Jul 2009
      • 31

      #3
      Hey Eco,

      I am sorry; accept my apologizes. Well we are experts in Cloud; I will write to you to discuss more on the subject. Thank you very much.

      Comment

      • ECO
        --Site Admin--
        • Oct 2007
        • 1360

        #4
        No problem at all! Welcome.

        Comment

        Latest Articles

        Collapse

        • SEQadmin2
          Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
          by SEQadmin2



          Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

          Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
          ...
          10-14-2026, 09:55 AM
        • SEQadmin2
          New Genomics Technologies Take Aim at Long-Standing Limits
          by SEQadmin2


          Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

          We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
          ...
          09-28-2026, 10:25 AM

        ad_right_rmr

        Collapse

        News

        Collapse

        Topics Statistics Last Post
        Started by SEQadmin2, 10-22-2026, 11:13 AM
        0 responses
        54 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 10-22-2026, 10:48 AM
        0 responses
        40 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 10-15-2026, 10:52 AM
        0 responses
        46 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 10-14-2026, 05:39 AM
        0 responses
        46 views
        0 reactions
        Last Post SEQadmin2  
        Working...